Diversified Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-406
Closed -$228K 1103
2025
Q4
$228K Buy
406
+2
+0.5% +$1.14K ﹤0.01% 924
2025
Q3
$208K Buy
+404
New +$176K ﹤0.01% 926
2024
Q3
Sell
-1,355
Closed -$558K 945
2024
Q2
$558K Sell
1,355
-417
-24% -$165K 0.02% 506
2024
Q1
$716K Sell
1,772
-606
-25% -$213K 0.02% 422
2023
Q4
$729K Sell
2,378
-3
-0.1% -$810 0.02% 383
2023
Q3
$577K Buy
2,381
+3
+0.1% +$767 0.02% 414
2023
Q2
$571K Buy
2,378
+742
+45% +$154K 0.02% 421
2023
Q1
$308K Buy
1,636
+536
+49% +$111K 0.01% 609
2022
Q4
$234K Buy
+1,100
New +$220K 0.01% 680

Other funds holding MEDP

Diversified Trust's MEDP Position: Q1 2026 in Review

Diversified Trust sold out of Medpace (MEDP) in Q1 2026, closing a stake of 406 shares — an estimated $228K sold.

Diversified Trust first reported a position in MEDP in Q4 2022 and held it in 9 quarters. The position peaked at $729K in Q4 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Diversified Trust reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Diversified Trust sold 406 Medpace shares in Q1 2026, an estimated $228K.
  • Diversified Trust first reported a position in Medpace in Q4 2022 and held it in 9 quarters.
  • Diversified Trust's Medpace position peaked at $729K in Q4 2023.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Diversified Trust's 13F filing for Q1 2026, filed 16 Apr 2026.